Substituted lactams and their use as anti-cancer agents

Details for Australian Patent Application No. 2004263287 (hide)

Owner Novartis AG

Inventors Kinder, Frederick Ray Jr.; Bair, Kenneth Walter; Versace, Richard William

Agent Davies Collison Cave

Pub. Number AU-B-2004263287

PCT Pub. Number WO2005/014574

Priority 60/490,415 25.07.03 US

Filing date 23 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 12 February 2009

International Classifications

C07D 223/12 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014574 Priority application(s): WO2005/014574

12 February 2009 Application Accepted

  Published as AU-B-2004263287

11 June 2009 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263296-Protein from Photobacterium damselae and use thereof

2004263286-Novel dibenzo(B,F)oxepine-10-carboxamides and pharmaceutical uses thereof